secwatch / observer
8-K filed May 30, 2023, 7:59 PM ET ticker LNSR CIK 0001320350
other material confidence high sentiment neutral materiality 0.15

LENSAR stockholders elect two Class III directors, ratify PwC, expand board to nine

LENSAR, Inc.

Key facts

Extracted from this filing and checked against the source text.

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

LENSAR, Inc. shareholders approved Election of two Class III directors to serve until the Company's annual meeting of stockholders to be held in 2026 and until their respective successors have been duly elected and qualified. at the 2023-05-25 meeting.

Proposal
director election
Outcome
passed
Meeting
2023-05-25
Exact text from the filing
Item 1 – Election of two Class III directors to serve until the Company’s annual meeting of stockholders to be held in 2026 and until their respective successors have been duly elected and qualified. Votes FOR Votes WITHHELD Broker Non-Votes William J. Link, PhD 5,883,023 1,117,236 1,917,061 Richard L. Lindstrom, MD 5,910,865 1,089,394 1,917,061
View on SEC.gov
Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

LENSAR, Inc. shareholders approved Ratification of the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2023. at the 2023-05-25 meeting.

Proposal
auditor ratification
Outcome
passed
Meeting
2023-05-25
Exact text from the filing
Item 2 – Ratification of the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2023. Votes FOR Votes AGAINST Votes ABSTAINED Broker Non-Votes 8,602,158 229,157 86,005 0
View on SEC.gov

Browse all shareholder votes →

LENSAR, Inc. filing history →

Source: SEC EDGAR
accession 0000950170-23-024814
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.